Clinical Trials
4 trialsNCT01577654 2021-04-01
TARGET
Endocyte
Phase 2 Completed
NCT03011320 2019-02-07
An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery
Endocyte
Phase 1 Completed
NCT00511485 2015-02-27
Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)
Endocyte
Phase 2 Completed
NCT01953536 2014-12-19
Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)
Endocyte
Phase 2 Withdrawn